Evidence map›Paper›PMID 22652643›Full record

ArticleFrontiers in bioscience (Elite edition)2012

GST P1, a novel downstream regulator of LRRK2, G2019S-induced neuronal cell death.

Jie Chen, Anthony Liou, Lili Zhang, Zhongfang Weng, Yanqin Gao, Guodong Cao, Michael J Zigmond, Jun Chen

Open access · bronzeAbstract read
In one paragraph

Article in Frontiers in bioscience (Elite edition), 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Glutathione metabolism and Parkinson's disease.Free radical biology & medicine · 2013
    Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Jie ChenState Key Laboratory of Medical Neurobiology and Institute of Brain Sciences, Fudan University School of Medicine, Shanghai, China, 200032.
Anthony Liou
Lili Zhang
Zhongfang Weng
Yanqin Gao
Guodong Cao
Michael J Zigmond
Jun Chen
Shanghai Medical College of Fudan University · CN

Funding

Stress Proteins and Neuroprotection Against Parkinsonian Cell DeathP01NS059806 · NINDS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI CHU, CHARLEEN T · 2009 to 2013
$6.3M
Mechanisms of Exercise-Induced Protection and Rescue in Models of Dopamine LossR01NS070825 · NINDS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI HOFFER, BARRY J, ZIGMOND, MICHAEL J · 2011 to 2014
$2.3M
Neuroprotection Against Parkinsonian Cell DeathR01NS062157 · NINDS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI CHEN, JUN · 2010 to 2014
$1.5M
NINDS NIH HHS NS059806NINDS NIH HHS NS062157NINDS NIH HHS P01 NS059806NINDS NIH HHS R01 NS062157NINDS NIH HHS R01 NS070825
6 · The paper itself

Abstract

The enhanced neurotoxicity of the Parkinson's disease-associated LRRK2 mutant, G2019S, than its wild-type counter-part has recently been reported. Overexpression of LRRK2 (G2019S) in cultured neural cells results in caspase-3-dependent apoptosis via a yet undefined signaling pathway. Elucidation of the mechanism underlying LRRK2 (G2019S) neurotoxicity may offer new insights into the pathogenesis of Parkinson's disease. In this study, we identified glutathione s-transferase P1 (GSTP1) as a selective target whose expression is negatively regulated at the transcriptional levels via promoter hyper-methylation by LRRK2 (G2019S). Overexpression of LRRK2 (G2019S) in the human neuronal cell line SH-SY5Y markedly suppressed the expression of GSTP1 prior to any manifestation of cell death. Moreover, shRNA-mediated knockdown of endogenous GSTP1 expression exacerbated LRRK2 (G2019S) neurotoxicity, whereas overexpression of GSTP1 protected against LRRK2 (G2019S)-induced caspase-3 activation and neuronal apoptosis. In conclusion, the results suggest a previously undefined signaling mechanism underlying the neurotoxic effect of LRRK2 (G2019S), in which LRRK2 (G2019S) triggers oxidative stress in cells and, in turn, results in caspase-dependent apoptosis at least in part by suppressing the expression of GSTP1.

Indexed as

Cell DeathBase SequenceBlotting, WesternCell Line, TumorDNA PrimersElectrophoresis, Polyacrylamide GelFluorescent Antibody Technique, IndirectGlutathione TransferaseHumansLeucine-Rich Repeat Serine-Threonine Protein Kinase-2NeuronsProtein Serine-Threonine KinasesReal-Time Polymerase Chain ReactionSpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationTandem Mass SpectrometryDNA PrimersGlutathione TransferaseLeucine-Rich Repeat Serine-Threonine Protein Kinase-2LRRK2 protein, humanProtein Serine-Threonine Kinases

Identifiers

PMID22652643
PMCPMC4174408
OpenAlexW2051048090

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.